Donald Reeves III Sells 255 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) SVP Donald Reeves III sold 255 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $80.88, for a total transaction of $20,624.40. Following the completion of the transaction, the senior vice president owned 29,419 shares in the company, valued at approximately $2,379,408.72. The trade was a 0.86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Itron Price Performance

ITRI stock opened at $83.02 on Friday. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 13.24, a PEG ratio of 0.73 and a beta of 1.35. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. Itron, Inc. has a 12-month low of $77.77 and a 12-month high of $142.00. The company’s fifty day simple moving average is $88.45 and its 200 day simple moving average is $94.52.

Itron (NASDAQ:ITRI) last released its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.23. The business had revenue of $586.98 million for the quarter, compared to analyst estimates of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, analysts expect that Itron, Inc. will post 6.01 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on ITRI. JPMorgan Chase & Co. dropped their target price on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Stephens restated an “overweight” rating and issued a $130.00 target price on shares of Itron in a report on Wednesday. Guggenheim set a $155.00 target price on shares of Itron in a report on Friday, February 13th. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. Finally, TD Cowen dropped their target price on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Hedge Funds Weigh In On Itron

Several large investors have recently added to or reduced their stakes in ITRI. Private Trust Co. NA boosted its stake in Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after purchasing an additional 145 shares during the last quarter. Employees Retirement System of Texas purchased a new stake in shares of Itron in the third quarter worth approximately $32,000. Optiver Holding B.V. purchased a new stake in shares of Itron in the third quarter worth approximately $36,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Itron by 29.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after purchasing an additional 101 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of Itron in the third quarter worth approximately $44,000. Institutional investors own 96.19% of the company’s stock.

More Itron News

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
• Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
• Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.